Journal of Leukocyte Biology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
QUICK SEARCH:   [advanced]


     

A more recent version of this article appeared on July 1, 2007

Published online before print April 5, 2007
This Article
Right arrow Full Text (Reprint (PDF))
Right arrow Supplemental Figures
Right arrow All Versions of this Article:
jlb.1006625v1
82/1/124    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Amatucci, A.
Right arrow Articles by Ibraghimov, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Amatucci, A.
Right arrow Articles by Ibraghimov, A.
© by The Society for Leukocyte Biology
Journal of Leukocyte Biology, doi:10.1189/jlb.1006625

Received for publication October 10, 2006.
Revised March 8, 2007.
Accepted for publication March 18, 2007.

Article

Recombinant ST2 boosts hepatic Th2 response in vivo

Aldo Amatucci @, Tatiana Novobrantseva , Kevin Gilbride , Margot Brickelmaier , Paula Hochman , and Alexander Ibraghimov

Biogen Idec, Cambridge, Massachusetts, USA

@ To whom correspondence should be addressed. E-mail: Aldo.Amatucci{at}biogenidec.com.


  Abstract

Excessive scarring or fibrosis is a common feature of a wide spectrum of diseases characterized by an exaggerated Th2 response. The TLR/IL-1 receptor (IL-1R)-related protein ST2 is expressed in a membrane-bound form selectively by Th2 cells and was shown to be indispensable for some in vivo Th2 responses. ST2 was also found to block TLR signaling. We addressed the impact of the ST2 pathway on fibrogenesis using a mouse model of hepatic injury and fibrosis induced by carbon tetrachloride (CCl4). We showed that cytokine production by intrahepatic lymphocytes from CCl4-injured liver is abrogated in the absence of TLR-4. Interfering with the ST2 pathway using an ST2-Fc fusion protein accelerated and enhanced hepatic fibrosis, paralleled by the increasing ex vivo secretion of Th2 cytokines IL-4, -5, -10, and -13 by intrahepatic lymphocytes of ST2-Fc-treated, CCl4-gavaged mice. Absence of IL-4/13 signaling in IL-4R{alpha}-deficient mice obliterated this ST2-Fc effect on fibrogenesis. Moreover, depletion of CD4+ T cells abrogated ST2-Fc-enhanced Th2 cytokines and accelerated fibrosis. Thus, ST2-Fc caused overproduction of Th2 cytokines by intrahepatic CD4+ T cells, possibly by modifying TLR-4 signaling in injured liver. This ST2-Fc-driven Th2 response exacerbated CCl4-induced hepatic fibrosis.

Key Words: liver • fibrosis






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2007 by the Society for Leukocyte Biology.